Category: neurological research

Weekend Links — Our Favorite Science Stories from the Web This Week

We’ve hand-picked a mix of Massachusetts General Hospital and other research-related news and science stories for your weekend reading enjoyment: Secrets of the Y Chromosome – It’s not just what makes males into males. The sex chromosome also influences health in hidden ways, some experts believe, and may even explain why men have shorter life spans. We ...

Learning Not to Fear: Mindfulness-Based Stress Reduction Improves Fear Extinction

Gunes Sevinc, PhD, is a postdoctoral research fellow in the lab of Sara Lazar, PhD, in the Department of Psychiatry at Massachusetts General Hospital. Her poster recently won an award at Mass General’s Research Fellow Poster Celebration. Continue reading to hear Dr. Sevinc explain her research: Being able to regulate one’s emotions is a critical ...

Looking for Insights to A Rare Genetic Neurologic Disease

Amanda Furness, PhD, is a postdoctoral research fellow in the Center for Genomic Medicine at Massachusetts General Hospital. Her poster, Therapeutic insight into Mucolipidosis IV via in vitro glia models, recently won an award at Mass General’s Research Fellow Poster Celebration. We asked Dr. Furness about her research: What problem(s) are you addressing with this ...

A Snapshot of Science

What’s new in research at Mass General? Here’s a snapshot of studies recently published in top-tier scientific journals: NEW INSIGHTS INTO HOW GENETICS INFLUENCE MIGRAINES Common Variant Burden Contributes to the Familial Aggregation of Migraine in 1,589 Families Gormley P, Kurki MI, Hiekkala ME, Veerapen K, Häppölä P [et al.], Palotie A Published in Neuron on May ...

New Imaging Protocol Could Vastly Accelerate Clinical Trials for New ALS Treatments

Researchers at Massachusetts General Hospital have developed a new technique for imaging the brains of patients with amyotrophic lateral sclerosis (ALS) that could vastly reduce the cost and time needed for new clinical trials—while also improving the accuracy of test results. Nazem Atassi, MD, the Associate Director of the Neurological Clinical Research Institute (NCRI) at ...

How New Biomarkers and Smartphone Apps Could Provide New Hope for ALS Patients

When a patient has strep throat, their care provider knows which antibiotics to prescribe to cure the ailment. But when a disease has no known cure, as is the case with amyotrophic lateral sclerosis (ALS), research often becomes part of clinical care. “There are still a lot of limitations in terms of what we can ...

Can Studying a Rare Inherited Form of ALS Lead to Earlier Diagnosis and New Treatments?

Hereditary forms of amyotrophic lateral sclerosis (ALS) may only account for 10 percent of all ALS cases, but the insights that researchers gain from studying this small population may be the key to unlocking new treatments for this devastating disease. That’s the hope of Katharine Nicholson, MD, a physician-investigator at the Neurological Clinical and Research ...

Weekend Links

We’ve hand-picked a mix of Massachusetts General Hospital and other research-related news and stories for your weekend reading enjoyment: Cancer Researcher Teamed Up With Superheroes – A new cancer awareness campaign by American Airlines features Mass General’s Marcela Maus, MD, PhD, along with other researchers and airlines staff who either have fought cancer or are still doing ...

Online Platform Accelerates Rare Disease Research

Earlier this week, the Mass General Neurological Clinical Research Center (NCRI)’s  NeuroBANK™ won Bio-IT World‘s Best Practice award in the Personalized & Translational Medicine category. What is the NeuroBANK, and how is it helping to accelerate the discovery, development, and delivery of future treatments for rare diseases including amyotrophic lateral sclerosis (ALS)? Filling a Need ...

Paganoni Advances ALS Research and Care with Technology

Technological advancements have revolutionized nearly every field of medicine from orthopedics to genetic testing. Sabrina Paganoni, MD, PhD, a clinician and researcher in the Neurological Clinical Research Institute (NCRI) at Massachusetts General Hospital, has seen firsthand the potential power and impact technology could have for amyotrophic lateral sclerosis (ALS). Paganoni is using technology to find ...